BioLife Solutions
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $25,421 | $23,941 | $-3,424 | $30,571 |
Gross Profit | 16,433 | 15,786 | 8,271 | 21,806 |
EBITDA | -14,330 | 166 | 6,747 | 853 |
EBIT | -15,712 | -1,218 | 5,043 | -1,464 |
Net Income | -15,838 | -448 | 12,459 | -1,703 |
Net Change In Cash | 25,421 | 23,941 | -3,424 | 30,571 |
Free Cash Flow | 5,625 | 1,552 | 583 | 3,688 |
Cash | 31,902 | 66,945 | 95,386 | 23,977 |
Basic Shares | 47,798 | 47,134 | 48,032 | 46,175 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $82,254 | $143,271 | $76,239 | $119,156 |
Gross Profit | 53,671 | 46,752 | 53,822 | 37,748 |
EBITDA | 1,532 | -45,238 | -124,182 | -16,654 |
EBIT | -7,129 | -57,533 | -144,140 | -29,519 |
Net Income | -20,184 | -66,427 | -139,805 | -8,908 |
Net Change In Cash | 82,254 | 143,271 | 76,239 | 119,156 |
Free Cash Flow | 5,204 | -18,879 | -18,874 | -13,221 |
Cash | 95,386 | 35,407 | 19,442 | 69,870 |
Basic Shares | 46,067 | 43,719 | 42,481 | 38,503 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.33 |
2025-03-31 | $0.03 |
2024-12-31 | -$0.01 |
